Li Haipeng, Wang Baolong, Xu Dongshuo, Zhang Jialu, Wang Changhui
Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, 230022 Hefei, Anhui, China.
Rev Cardiovasc Med. 2024 Dec 11;25(12):434. doi: 10.31083/j.rcm2512434. eCollection 2024 Dec.
With ageing and lifestyle changes, the coexistence of osteoporosis and type 2 diabetes (T2DM) is becoming more common, which greatly increases patient disability and mortality. However, the association of low bone mineral density (BMD) with cardiovascular disease (CVD) and all-cause mortality in T2DM patients have not been conclusively established.
Using the National Health and Nutrition Examination Survey (NHANES) to obtain a nationally representative sample of the US population, we sought to determine the independent and incremental value of low BMD, particularly in patients with osteoporosis in assessing all-cause and CVD mortality in adults with T2DM.
We demonstrated that increased BMD was significantly related to decreased mortality from all-causes and CVDs among US adults with T2DM. In addition, we found that, after multivariate adjustment, osteoporosis and osteopenia were independently associated with an increased risk of all-cause and CVD mortality in T2DM patients at long-term follow-up.
The clinical diagnosis of osteopenia or osteoporosis in adults with T2DM provides independent prognostic value for CVD and all-cause mortality.
随着老龄化和生活方式的改变,骨质疏松症与2型糖尿病(T2DM)并存的情况越来越普遍,这大大增加了患者的残疾率和死亡率。然而,2型糖尿病患者低骨密度(BMD)与心血管疾病(CVD)及全因死亡率之间的关联尚未得到确凿证实。
利用美国国家健康与营养检查调查(NHANES)获取具有全国代表性的美国人群样本,我们试图确定低骨密度,特别是骨质疏松症患者的低骨密度在评估2型糖尿病成年患者全因死亡率和心血管疾病死亡率方面的独立及增量价值。
我们证明,在美国2型糖尿病成年患者中,骨密度增加与全因死亡率和心血管疾病死亡率降低显著相关。此外,我们发现,经过多变量调整后,在长期随访中,骨质疏松症和骨质减少与2型糖尿病患者全因死亡率和心血管疾病死亡率增加的风险独立相关。
2型糖尿病成年患者中骨质减少或骨质疏松的临床诊断对心血管疾病和全因死亡率具有独立的预后价值。